January 10–11, 2017
Parc 55 San Francisco – A Hilton Hotel,
San Francisco, CA
THANK YOU FOR ATTENDING DIGITAL MEDICINE SHOWCASE
Digital Medicine Showcase 2017: At the intersection of technology and medicine
How will new digital technologies impact disease management and healthcare over the next decade? How will new digital technologies impact disease management and healthcare over the next decade?
Whitepaper authored by Forbes contributor, Nicole Fisher, and features insights from Evidation Health, Hogan Lovells, J&J, NIH/PMI, Sanofi, StartUp Health, and key opinion leaders such as John Nosta and Unity Stoakes.
- Produced by EBD Group in collaboration with Hogan Lovells
Who participates in Digital Medicine Showcase?
Digital Medicine Showcase brings together innovative companies showcasing clinically impactful digital health technologies, venture capital and private equity investors, pharma executives and professional advisors.
LEFT: Adherium CEO Garth Sutherland, a 2016 presenter at Biotech Showcase and Digital Medicine Showcase, explains the connected platform created by its Smartinhaler technology.
Digital Medicine Showcase provides companies with resources to connect with the right partners and advance new technologies to market.
Present your company to an investor audience
A curated group of innovative digital medicine companies will share their plans for changing the way diseases will be monitored and treated in the future.
Discuss industry trends and challenges
The Digital Medicine Showcase program will include a state of the industry plenary, panels and workshops covering partnerships, investment and regulatory paths.
Make connections at Biotech Showcase
Digital Medicine Showcase offers attendees the opportunity to also attend Biotech Showcase programs and presentations on January 10–11.